Develop and execute a global training strategy tailored to cell therapy programs across clinical and commercial stages.
Build role-specific onboarding, certification, and continuous learning pathways for Medical and Commercial field teams.
Deliver comprehensive training including disease state education, CAR T product design, clinical data, safety monitoring, and competitive landscape.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases. It is a scaling biotech environment with a culture driven by core values of collaboration, clarity, innovation, and ownership.
Develop and execute strategic account plans across health systems, IDNs, and treatment centers.
Lead treatment center activation, onboarding, contracting, operational readiness, and site certification.
Serve as the primary customer contact for CAR-T/cell therapy operations, logistics, and order management.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases. The company is guided by core values and is committed to transforming the future of treatment for autoimmune disease.
Lead evidence generation planning, investigator-sponsored trials, and medical information strategy for a rare disease portfolio.
Drive global medical planning and alignment, integrating AI into Medical Affairs workflows.
Oversee expanded access programs, build scalable operating models, and ensure compliance across all medical activities.
BridgeBio pioneers a 'moneyball for biotech' approach, pooling early-stage research projects to reduce risk and advance rare disease treatments. They value curiosity, experimentation, and ethical use of AI, fostering a culture of pushing boundaries and empowering teams to solve problems.
Lead and develop clinical operations teams, overseeing oncology trial execution from feasibility to closeout.
Drive process improvements and operational excellence to enhance study delivery and site performance.
Ensure compliance with regulations, manage budgets and resources, and foster stakeholder relationships.
The company is a global clinical development organization focused on advancing oncology therapies through clinical trials. It fosters a collaborative and inclusive work environment with opportunities for professional growth and continuous learning.
Lead integrated asset strategy across the full lifecycle, including research, clinical development, and commercialization.
Drive strategic planning for emerging therapeutic platform technologies and evaluate portfolio opportunities.
Ensure alignment across Clinical Development, Manufacturing, Quality, Regulatory, and Commercial teams for late-stage development and launch planning.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by core values like 'Stay True to Why' and 'Collaborate to Accelerate,' they are a committed team transforming autoimmune disease treatment.
Lead all operational and lifecycle management aspects of Regulatory CMC submissions supporting cell therapy development programs.
Develop and execute global regulatory CMC strategies aligned with program objectives and regulatory requirements.
Serve as Regulatory CMC lead on cross-functional program teams, providing strategic regulatory guidance for cell therapy development.
BrainChild Bio is a kids-first company focused on developing innovative cell therapies for patients with devastating diseases. We are a small, mission-driven company with a rapidly growing, dynamic environment.
Define and execute long-term product vision and growth roadmap for respiratory solutions.
Lead global product launches and go-to-market strategies with cross-functional teams.
Analyze market insights and competitive landscape to drive portfolio expansion and innovation.
Our partner is a global life sciences company focused on respiratory diagnostics and innovative healthcare solutions. The company emphasizes collaboration, employee wellbeing, and professional growth within a remote-first culture.
Provide sponsor oversight of CMO QC labs and maintain control strategies for investigational cell therapy products.
Manage validation of analytical methods and stability programs to support clinical trials.
Investigate laboratory deviations and ensure risks are managed to resolution.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases. Guided by core values of innovation and collaboration, they are a growing company committed to transforming treatment for autoimmune disease.
Designs and leads a comprehensive field manager development program spanning new manager onboarding to advanced leadership curricula.
Builds and manages a high-potential identification and development framework for field talent.
Evaluates and integrates external leadership development resources and measures program effectiveness.
Azurity Pharmaceuticals is a privately held specialty pharmaceutical company focused on innovative products for underserved patients. The company's success is driven by a talented, dedicated team that brings science and commitment to quality.
Shape and advance the enterprise training strategy and multi-year roadmap for medical and scientific capability building across the Global Development Organization.
Partner with senior and executive leaders to translate organizational priorities into scalable, measurable training programs that strengthen role readiness and scientific excellence.
Provide strategic oversight of learning architecture, certification frameworks, and training effectiveness, ensuring alignment with Medical Affairs strategy and adult learning principles.
Ultragenyx is a biopharmaceutical company dedicated to leading the future of rare disease medicine by challenging the status quo and creating a new model to bring life-changing treatments to patients. The company fosters a supportive and inclusive culture of profound learning and growth, committed to employee well-being and professional development.
Serve as a subject matter expert in stem cell transplantation and cell therapy, fostering deep scientific relationships with key opinion leaders and healthcare providers.
Prepare and manage a territory plan, engage with field team members to support treatment center authorization and adverse event reporting.
Gather and communicate actionable scientific insights from congresses and stakeholder interactions to inform medical strategy and evidence generation.
Orca Bio is a commercial-stage biotechnology company developing next-generation cell therapies to improve outcomes for blood cancer patients undergoing stem cell transplants. It maintains a start-up culture of camaraderie, leadership by example, and a passion for science and compassion for patients.
Lead cross-functional market access strategy to optimize access for oncology launch and inline brands.
Partner with subject matter experts to analyze payer coverage, affordability, and industry trends.
Hire and develop a team of experts in US market access to drive sustainable value for patients.
Novartis is a global healthcare company that develops innovative medicines to improve patient lives. They are a large organization with a collaborative, agile culture focused on patient access and empowering employees.